Medicare Enrolled

Dr. Tania Paquin Lozano, MD

Endocrinology · Tampa, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
6101 WEBB RD, Tampa, FL 33615
8139015038
In practice since 2005 (20 years)
NPI: 1477538890 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Paquin Lozano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Paquin Lozano? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Paquin Lozano

Dr. Tania Paquin Lozano is an endocrinology in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Paquin Lozano performed 996 Medicare services across 502 unique beneficiaries.

Between the years covered by Open Payments, Dr. Paquin Lozano received a total of $27,594 from 63 pharmaceutical and/or device companies across 1273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Paquin Lozano is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 44% volume in FL$ $27,594 industry payments

Medicare Practice Summary

Medicare Utilization ↗
996
Medicare services
Top 44% in FL for endocrinology
502
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~50 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report443$25$49
Office visit, established patient, complex (40-54 min)306$126$252
Office visit, established patient (30-39 min)171$90$180
Office visit, established patient (20-29 min)61$70$127
New patient office visit, complex (60-74 min)15$151$310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$27,594
Total received (2018-2024)
Avg $3,942/year across 7 years
Top 14% in FL for endocrinology
63
Companies
1,273
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,495 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,099 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,342
2023
$4,316
2022
$4,535
2021
$6,001
2020
$3,372
2019
$2,507
2018
$2,521

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$3,409
SANOFI-AVENTIS U.S. LLC
$2,882
Lilly USA, LLC
$2,163
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,124
AstraZeneca Pharmaceuticals LP
$1,930
Abbott Laboratories
$1,171
Corcept Therapeutics
$1,125
Amneal Pharmaceuticals LLC
$916
Bayer Healthcare Pharmaceuticals Inc.
$850
Mannkind Corporation
$828
Amarin Pharma Inc.
$736
MannKind Corporation
$711
Merck Sharp & Dohme Corporation
$708
Amgen Inc.
$656
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$563
Radius Health, Inc.
$494
IBSA Pharma Inc.
$473
Xeris Pharmaceuticals, Inc.
$446
Janssen Pharmaceuticals, Inc
$377
SANOFI US SERVICES INC.
$350
GENZYME CORPORATION
$317
Bayer HealthCare Pharmaceuticals Inc.
$290
Nevro Corp.
$251
Dexcom, Inc.
$218
Valeritas, Inc.
$214
CeQur Corporation
$211
Acella Pharmaceuticals, LLC
$210
ABBVIE INC.
$185
Insulet Corporation
$165
Merck Sharp & Dohme LLC
$161
Zealand Pharma US, Inc.
$153
Lexicon Pharmaceuticals, Inc.
$142
Antares Pharma, Inc.
$134
AbbVie Inc.
$133
AbbVie, Inc.
$127
Esperion Therapeutics, Inc.
$125
UCB, Inc.
$123
Tandem Diabetes Care, Inc.
$122
Amryt Pharma Holdings Ltd
$122
Clarus Therapeutics Inc.
$107
Horizon Therapeutics plc
$105
Vapotherm Inc
$105
DEXCOM, INC.
$104
Novartis Pharmaceuticals Corporation
$103
Medtronic, Inc.
$90
RECORDATI_RARE_DISEASES_INC.
$88
Avvisto Therapeutics, LLC
$64
Emergent BioSolutions Inc.
$57
GRT US Holding, Inc.
$54
Medtronic MiniMed, Inc.
$53
Kyowa Kirin, Inc.
$50
Acerus Pharmaceuticals Corporation
$42
Ultragenyx Pharmaceutical Inc.
$38
Roche Diabetes Care, Inc.
$36
Supernus Pharmaceuticals, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$24
Azurity Pharmaceuticals, Inc.
$23
Shire North American Group Inc
$19
Tolmar, Inc.
$18
Astellas Pharma US Inc
$18
Ferring Pharmaceuticals Inc.
$17
Ascensia Diabetes Care Us Inc.
$16
PFIZER INC.
$16
Top 3 companies account for 30.6% of total payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BASAGLAR · BYDUREON · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DC ACCU-CHEK Guide · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre 2 · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN U · INVOKANA · Inpefa · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kit and Accessories · Korlym · LEQVIO · LICART · LOKELMA · LYRICA · LYUMJEV · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NEXLETOL · NOCDURNA · NP Thyroid · NP Thyroid 60 · Narcan · Natesto · Omnia · Omnipod · Ozempic · Precision Flow · Proclaim Family of SCS IPGs · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · Senza · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEGALOGUE · ZOMACTON · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,770 per 100 Medicare services performed
Looking for a endocrinology in Tampa?
Compare endocrinologys in the Tampa area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
74
Per 100K population
5.0
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
4.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Paquin Lozano is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 14%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Paquin Lozano experienced with continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report?
Based on Medicare claims data, Dr. Paquin Lozano performed 443 continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Paquin Lozano receive payments from pharmaceutical companies?
Yes. Dr. Paquin Lozano received a total of $27,594 from 63 companies across 1,273 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Paquin Lozano's costs compare to other endocrinologys in Tampa?
Dr. Paquin Lozano's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Paquin Lozano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →